Loading clinical trials...
Loading clinical trials...
This study is exploring whether it's possible to detect paragangliomas (a rare type of tumor) during minimally invasive surgery by using a technique called near-infrared fluorescence imaging, guided by a substance called indocyanine green (ICG). The goal is to see if this method can help surgeons identify and treat paragangliomas more accurately and during minimally invasive procedures.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Leiden University Medical Center
Leiden, Netherlands
Start Date
November 11, 2023
Primary Completion Date
December 30, 2023
Completion Date
February 20, 2024
Last Updated
December 4, 2023
6
ESTIMATED participants
Fluorescence guided identification using indocyanine green
DRUG
Lead Sponsor
Leiden University Medical Center
NCT04924075
NCT03050268
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions